Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer/interface version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T22:25:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:01.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The latest version adds multiple study-record sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Design, Study Status) and marks 'Returned' on 2026-04-07, with Quality Control status noted as not concluded.
    Difference
    0.9%
    Check dated 2026-04-10T09:13:13.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Results status changed from No Results Posted to Results Submitted. Revision updated to v3.5.0 (replacing v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-20T00:17:03.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.3, replacing the previous v3.4.2 revision.
    Difference
    0.1%
    Check dated 2026-03-12T21:29:10.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry, v3.4.2, has been added to the history. The previous entry, v3.4.1, has been removed.
    Difference
    0.1%
    Check dated 2026-02-12T02:18:41.000Z thumbnail image

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.